Feasibility, complications, morbidity, and mortality results at 6 months for aneurysm treatment with the Flow Re-Direction Endoluminal Device: report of SAFE study.

Laurent PierotLaurent SpelleJérôme BergeAnne-Christine JanuelDenis HerbreteauMohamed AggourMichel PiotinAlessandra BiondiXavier BarreauCharbel MounayerChrisanthi PapagiannakiJean-Paul LejeuneJean-Yves GauvritVincent Costalat

Published in: Journal of neurointerventional surgery (2018)

NCT02921698.

Keyphrases

coronary artery
risk factors
combination therapy
abdominal aortic aneurysm